Repaglinide

Primary Use

Repaglinide is a prescription medication indicated for the treatment of type 2 diabetes mellitus in adults. It is used to improve glycemic control (blood sugar levels) when diet and exercise alone are not sufficient.

How It Is Prescribed

This medication may be used in different treatment plans depending on the patient's needs:

• Monotherapy: It can be used as the only medication for blood sugar management.
• Combination Therapy: It is frequently prescribed alongside other diabetes medications, such as metformin or thiazolidinediones, when one drug alone does not provide enough control.

Important Considerations

Repaglinide is specifically for type 2 diabetes. It is not used to treat type 1 diabetes or diabetic ketoacidosis. Proper management of blood sugar is essential to reduce the risk of long-term complications, including kidney damage, nerve issues, vision loss, and cardiovascular problems.

Mechanism of Action

Repaglinide belongs to a class of medications called meglitinides. It works by helping the pancreas produce more insulin, which is the hormone that allows the body to properly use and store sugar from food.

The medication works in the following ways:

• Stimulating Insulin Release: Repaglinide binds to specific sites on the beta cells in the pancreas. This action triggers the release of insulin into the bloodstream.
• Mealtime Control: Because it is absorbed quickly and starts working soon after it is taken, it is primarily used to control the rise in blood sugar that happens immediately after eating a meal.
• Glucose Dependence: The effectiveness of the drug depends on the presence of glucose. As blood sugar levels fall, the amount of insulin stimulated by the medication also decreases.

Repaglinide requires functioning beta cells in the pancreas to work effectively. It is used specifically for type 2 diabetes and is not a treatment for type 1 diabetes, a condition where the pancreas does not produce any insulin.

Common Side Effects

Some people may experience mild side effects while taking repaglinide. These often include:

• Headache
• Diarrhea, nausea, or heartburn
• Joint or back pain
• Symptoms of a cold, such as a runny nose, sneezing, or sore throat
• Sinus irritation or cough

Serious Side Effects

Contact your doctor immediately or seek emergency medical care if you experience any of the following serious side effects:

• Low blood sugar (hypoglycemia): This is a common but potentially serious side effect. Symptoms may include extreme hunger, blurred vision, shakiness, sweating, fast heartbeat, dizziness, or confusion. Severe hypoglycemia can lead to seizures or loss of consciousness.
• Allergic reactions: Signs include a skin rash, itching, hives, or swelling of the face, lips, tongue, or throat.
• Vision changes: Any sudden changes in your ability to see clearly.
• Chest pain: Discomfort or pressure in the chest area.
• Difficulty breathing: Shortness of breath or trouble swallowing.

Hypoglycemia (Low Blood Sugar)

The most common risk associated with repaglinide is hypoglycemia. This risk increases if a meal is skipped, if physical activity is unusually intense, or if alcohol is consumed. Symptoms of low blood sugar may include dizziness, sweating, confusion, and shakiness.

Drug Interactions

Repaglinide must not be taken with gemfibrozil (a cholesterol medication) because it can cause repaglinide levels to rise significantly, leading to severe low blood sugar. Caution is also advised when taking clopidogrel or cyclosporine, as these may also increase the levels of repaglinide in the body.

Contraindications

This medication is not for everyone. It should not be used by people with:

• Type 1 diabetes
• Diabetic ketoacidosis
• A known allergy to repaglinide or any of its ingredients

Medical Conditions and Monitoring

Individuals with liver or kidney disease may be more sensitive to the effects of repaglinide and may require lower starting doses and frequent monitoring. During periods of physical stress, such as fever, infection, trauma, or surgery, blood sugar control may be lost, and a temporary switch to insulin might be necessary.

Pregnancy

There are no adequate and well-controlled studies on the use of repaglinide in pregnant women. In animal studies, high doses of the medication were associated with skeletal abnormalities in the offspring. Because maintaining stable blood sugar levels is critical during pregnancy, healthcare providers often recommend insulin instead of oral medications like repaglinide.

If you are pregnant or planning to become pregnant, consult your healthcare provider to discuss the best treatment plan for your situation.

Breastfeeding

It is unknown whether repaglinide is excreted in human breast milk. However, studies in animals have shown that the drug can pass into milk. Due to the risk of serious adverse reactions in a nursing infant, such as severely low blood sugar, a decision must be made to either stop breastfeeding or stop taking the medication.

Speak with your doctor about the risks and benefits of breastfeeding while using this medication.

Available Forms

Repaglinide is available in the following oral dosage forms:

• Oral Tablet: This medication is available as a standalone tablet to be taken by mouth.
• Combination Tablet: Repaglinide is also available as a combination tablet that contains both repaglinide and metformin.

FDA Approval and Indications

Repaglinide was first approved by the U.S. Food and Drug Administration (FDA) in 1997. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.

Regulatory Warnings

Repaglinide does not currently have a boxed warning. However, the FDA-approved labeling includes a significant contraindication regarding its use with gemfibrozil, a medication used to lower cholesterol. Taking these two medications together can cause repaglinide levels in the blood to rise significantly, which may lead to severe and prolonged low blood sugar (hypoglycemia).

Prescription Status

Repaglinide is available only by prescription and is currently marketed as a generic medication. It may be prescribed alone or in combination with other oral glucose-lowering agents, such as metformin or thiazolidinediones, when a single medication does not provide adequate blood sugar control.

Generic Availability

Repaglinide is available as a generic medication. Generic versions contain the same active ingredients as brand-name drugs but are typically available at a lower cost. Choosing the generic form is often the most effective way to reduce the price of this medication.

Insurance and Medicare Coverage

Most health insurance plans and Medicare Part D provide coverage for generic repaglinide. The specific out-of-pocket cost, such as a copayment or coinsurance, will depend on the individual plan's formulary and tier placement for the drug.

Factors Affecting Retail Price

The price paid at the pharmacy can vary based on several factors:

• Pharmacy Choice: Retail prices may differ between various chain pharmacies, independent pharmacies, and mail-order services.
• Quantity: Filling a 90-day supply may sometimes offer a lower cost per tablet compared to a 30-day supply.
• Savings Programs: For those without insurance, pharmacy discount cards or manufacturer assistance programs may help lower the retail price.